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Abstract
Background: Host responses to viral infection include both immune activation and programmed cell death. The
mitochondrial antiviral signaling adaptor, MAVS (IPS-1, VISA or Cardif) is critical for host defenses to viral infection by
inducing type-1 interferons (IFN-I), however its role in virus-induced apoptotic responses has not been elucidated.
Principal Findings: We show that MAVS causes apoptosis independent of its function in initiating IFN-I production. MAVS-
induced cell death requires mitochondrial localization, is caspase dependent, and displays hallmarks of apoptosis.
Furthermore, MAVS
2/2 fibroblasts are resistant to Sendai virus-induced apoptosis. A functional screen identifies the
hepatitis C virus NS3/4A and the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) nonstructural protein (NSP15)
as inhibitors of MAVS-induced apoptosis, possibly as a method of immune evasion.
Significance: This study describes a novel role for MAVS in controlling viral infections through the induction of apoptosis,
and identifies viral proteins which inhibit this host response.
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Introduction
In recent years, knowledge of host cell signaling responses to
viral infection has progressed rapidly. It is known that cells of the
immune system contain toll-like receptors (TLRs) capable of
detecting extracellular or endosomal viral nucleic acid and
activating appropriate signal transduction pathways leading to
the up-regulation of immune and inflammatory cytokines. Besides
detecting extracellular viral products, somatic cells can also
respond to intracellular viral RNA by activating the recently
identified mitochondrial antiviral signaling pathway. Following
cytoplasmic detection of viral nucleic acid by the RIG-I-like
helicases (RLH) family of receptors, these and other signaling
proteins are recruited to the mitochondria where they interact
with the mitochondrial antiviral signaling adaptor protein MAVS
(IPS-1, VISA and Cardif) [1,2,3,4]. In vitro and In vivo experiments
have revealed a critical role for MAVS and its mitochondrial
localization in the activation of host antiviral responses [1,5].
Although the role of MAVS in type-1 interferon (IFN-I) responses
is known, the localization of MAVS to the mitochondria suggests
other putative mitochondrial functions for MAVS, prominent
among these is apoptosis. However, to date, there are no
comprehensive studies focused on testing this hypothesis. Notably,
host cell apoptosis is a successful strategy to impede viral replication
and restrict virus spreading during a productive infection [6].
Multicellular organisms are equipped with at least two
evolutionarily conserved defensive arms to eradicate viral
infections: programmed cell death and innate immune responses.
Many proteins which function in both apoptotic and inflammatory
signaling cascades contain a caspase recruitment domain (CARD),
which functions as a homotypic interaction motif. In fact, the
biological function of the CARD domain was initially described in
a subset of caspases which activate mitochondria-dependent
apoptotic signaling [7]. For example, the CARD containing
Apaf-1 (apoptosis protease-activating factor-1) protein binds to
cytochrome c and forms a ternary multimeric protein structure
called the apoptosome which functions to activate caspase-9 via a
proximity-induced mechanism [8]. Other CARD-containing
proteins including some members of the NLR (nucleotide-binding
domain and leucine-rich repeat containing) protein family have
been linked with both apoptotic and inflammatory signaling [9].
For example, the CARD-containing NLR, Nod1, has been shown
to activate a caspase-9 dependent apoptosis and play a positive
regulatory role in pathogen-induced NF-kB activation [10].
Similarly, Nod2, a protein linked with the etiology of the
autoinflammatory Crohn’s disease, has been reported to augment
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CARD-containing NLR, Nlrc4 (Ipaf), mediates cell death through
a caspase-1 dependent fashion [12,13,14].
Similar to the aforementioned proteins, MAVS contains an N-
terminal CARD-like domain, in addition to a central proline-rich
region and a C-terminal transmembrane (TM) domain, which
targets MAVS to the mitochondrial outer membrane [1]. Recent
crystal structure analysis reveals that the CARD-like domain of
MAVS is indeed a classical CARD fold with surface charge
profiles of a typical CARD domain involved in homotypic
associations [15]. Consequently, the presence of a CARD-like
domain coupled with its mitochondrial localization suggests a
putative role for MAVS in both immune and cell death responses.
In fact, both the N-terminal CARD-like and TM domains are
indispensable for MAVS-mediated activation of interferon regu-
latory factor-3 (IRF-3) and subsequent transcription of the
antiviral IFN-I, suggesting that these domains are critical to
MAVS function [1]. As a survival mechanism, it is known that
some viruses have evolved strategies to inhibit MAVS function
throughselectivetargetingofthesefunctionaldomains.Forexample,
the genome of hepatitis C virus (HCV) has evolved to include a
serineprotease, NS3/4A, whichcleaves the MAVSTMdomain and
dislodges MAVS from the mitochondria, thereby abrogating MAVS
mediated IFN-Iproduction[4,16]. Similarto HCV,hepatitisAvirus
(HAV) encodes for the 3ABC protein, which localizes to the
mitochondria and inhibits MAVS signaling via proteolytic cleavage
[17,18]. Currently, there are no reports of viral proteins targeting
MAVS for inhibition of virus-induced cell death responses.
Host cell apoptosis has been reported to suppress viral
replication and the subsequent production of infectious progeny
viruses [19]. For example, adenoviruses and baculoviruses which
are defective in anti-apoptotic genes are compromised in
producing progeny viruses [19]. In addition, several viruses
infectious to humans, including the coronaviruses, are known to
modulate host cell apoptotic responses [20,21]. In 2003,
researchers from several labs identified a unique coronavirus
linked with the pathogenesis of severe acute respiratory syndrome
(SARS) in humans [22,23,24]. The spread of SARS-CoV,
reaching near pandemic levels, resulted in the death of over 900
individuals with a case fatality rate of 11% [25]. Since that time,
the sequencing of the complete SARS-CoV genome has allowed
scientists to study the function of each SARS-CoV encoded
protein in greater details. Phylogenetic analyses revealed that
SARS-CoV was not closely related to any other characterized
coronaviruses [26,27]. The distinct nature of the SARS-CoV
genome suggests possible unique strategies employed by this virus
to subvert host defense mechanisms. Notably, unlike other
common human respiratory viral infections, such as influenza A
virus, the viral loads in the upper airway of SARS patients
progressively increase, reaching a peak around 10 days after the
initial onset of symptoms [28]. This indicates that at least during
the initial stages of SARS-CoV infection, this virus might suppress
host defensive responses. In fact, several SARS-CoV proteins have
been shown to inhibit host IFN-I responses [20,21,29]. Although
the fact that certain clinical manifestations of SARS such as
lymphopenia and cell death in the lung or liver are thought to be
related to the ability of SARS-CoV to induce apoptosis in specific
cell types and that several pro-apoptotic proteins have been found
in SARS-CoV genome [30,31,32], the early pathogenesis of SARS
is poorly understood and how apoptosis contributes to the initial
pathological changes is largely unknown. In addition, the
replication of SARS-CoV seems to be restrained to the first two
weeks upon symptom onset with little evidence of continued
replication after this time window [33]. Clearly, the temporal and
cell-type specific expression of SARS-CoV proteins could account
for the dynamics of SARS-CoV infection and given that host cell
fate decisions are a part of overall host responses to any pathogen,
it is conceivable that like SARS-CoV inhibitory effects on IFN-I
responses, this virus could employ proteins which function as
inhibitors of host cell death. In this report, we describe a novel
function of MAVS in mediating virus-induced apoptosis, and
identify viral proteins as inhibitors of this response.
Results
MAVS induces caspase-dependent apoptosis
Transient expression of MAVS protein causes HEK293T cells
to crenate and lose adherence, suggesting that MAVS is cytotoxic
(Fig. 1A). Although some cell death was observed at 24 hours post-
transfection, it was most evident at 48 hours post-transfection,
which was quantitated by the Trypan blue exclusion test of cell
viability. In this assay, we observed a dose-dependent increase in
the percentage of Trypan blue positive cells at 48 hours post-
transfection with MAVS plasmid (Fig. 1B). This result was
confirmed by measurements of cell viability via XTT assay.
MAVS-induced cell death is potent as 10 ng of MAVS plasmid
was sufficient to decrease cell viability by 40% (Fig. 1C).
MAVS contains a N-terminal CARD-like domain, which is well
conserved from human to pufferfish [1]; and the CARD domain of
other proteins has been shown to mediate the activation of
caspases, facilitating apoptosis [34]. Therefore, we next sought to
test the hypothesis that MAVS induces apoptosis through a
caspase-dependent mechanism. It is well known that blockade of
caspase activity will inhibit the intrinsic apoptotic pathway [35].
Thus, we treated HEK293T cells with a pan-caspase inhibitor (Z-
VAD-FMK) followed by transfection of increasing amounts of
MAVS plasmid. As expected, transient MAVS expression in
untreated cells resulted in a significant loss of cell viability as
measured by XTT assay (Fig. 2A, black bars); and application of
the pan-caspase inhibitor resulted in a complete reversal of
MAVS-induced cell death (Fig. 2A, grey bars). It is known that
caspase-dependent apoptosis can cause Poly (ADP-ribose) Poly-
merase (PARP) cleavage, thus we investigated the effect of MAVS
expression on the triggering of PARP cleavage. HEK293T cells
were transfected with two different doses of MAVS plasmid and
both adherent and floating cells were harvested and lysed 24 and
48 hours post-transfection. Immunoblotting followed by densi-
tometry measurements revealed a dose-dependent increase in
PARP cleavage (Fig. 2B, 2C). In congruence with the PARP
cleavage pattern, caspases-3 and caspase-9 protein levels also
showed dose-dependent increases following MAVS expression
(Fig. 2B, 2C). Transmission electron microscopy examination of
HEK293T cells transfected with MAVS or empty vector was
performed at 48 hours post-transfection (Fig. 2D). Unlike the
otherwise healthy cells transfected with empty vector (Fig. 2D, top
panel), MAVS-expressing cells exhibit the morphological hall-
marks of apoptosis including an intact plasma membrane (Fig. 2D,
bottom panel arrow I), crenation, condensed and marginated
chromatin (arrow II), large vacuoles (arrow III), cytoplasm
shrinkage, membrane blebbing, an intact nuclear envelope, and
swollen mitochondria (arrow IV) [36]. A kinetic analysis shows
that MAVS expression reached a peak at 24 h post-transfection
(Fig. S1A), while MAVS-associated apoptosis lagged behind
reaching a peak at 48 h post-transfection (Fig. S1B). Thus the
late onset of apoptosis does not appear to be due to the lack of
MAVS expression. It is possible that there are several molecular
steps that have to occur before MAVS could cause caspase-3 and
caspase-9 activation, leading to apoptosis.
MAVS Mediates Apoptosis
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requires MAVS
The aforementioned studies analyzed the effect of transient
expression of MAVS on cell death. To explore the physiological
role of endogenous MAVS in mediating virus-induced apoptosis,
we extended these findings to investigations of recombinant Sendai
virus expressing GFP (rSeV-GFP) infected mouse embryonic
fibroblasts (MEFs) isolated from MAVS knockout or wild type
littermate control mice. MAVS deficiency was confirmed by
Western blot (Fig. S2). At 48 hours post-infection, we infected
MAVS
2/2 and wildtype littermate control MEFs with rSeV-GFP,
which is a known inducer of apoptosis [37]. Infection efficiency in
each cell line was monitored by GFP positivity, which was similar
between MAVS wildtype and knockout MEFs (Fig. 3A, top
graph). In contrast, the percentage of Annexin V positive cells was
.30% among infected wildtype MEFs compared to ,8% for the
MAVS
2/2 MEFs (Fig. 3A, bottom graph). Similarly, MAVS-
deficient MEFs maintained a spindle-like fibroblastic morphology
(Fig. 3B, GFP bottom panel), while wildtype MEFs crenated and
became detached from the plate. In addition, rSeV-GFP infected
wildtype MEFs have higher propidium iodide/Hoechst staining
ratio as compared to MAVS
2/2, further indicating an increase in
cell death (Fig. 3B, Hoechst and PI panels). Transmission electron
micrographs taken for both cell types, with or without SeV,
demonstrated that SeV infection resulted in the presence of typical
apoptotic features in the wildtype MEFs (Fig. 3C, left panels).
However, SeV infected MAVS
2/2 showed little signs of apoptosis
and are indistinguishable from the uninfected controls (Fig. 3C,
right panels).
Mitochondrial localization is required for MAVS-induced
apoptosis
Previous reports have shown that the MAVS C-terminal
transmembrane domain (TM) is essential to MAVS function as
an adaptor in IFN-I signaling [1]. Therefore we sought to
determine the essential domain that mediates MAVS-induced
apoptosis. We expressed full length MAVS protein or three
truncation mutants (Fig. 4A) in HEK293T cells and measured
Annexin V and 7-AAD staining. The MAVSDTM mutant, which
lacks the mitochondrial transmembrane sequence, was completely
incapable of inducing apoptosis, suggesting that similar to the role
of MAVS in interferon signaling, mitochondrial localization is
essential to MAVS activation of apoptosis (Fig. 4B, top right
panel). Truncation of the MAVS CARD domain (MAVSD-
CARD) significantly inhibited MAVS-induced apoptosis, but to a
lesser extent than the aforementioned MAVSDTM mutant
(Fig. 4B, bottom left panel). Truncation of the MAVS proline
rich region (MAVSDProl) had little effect on MAVS-induced
apoptosis (Fig. 4B, bottom middle panel). All the MAVS
truncation mutants were expressed well (Fig. S3A, S3B), thus
inability of these constructs to induce apoptosis is not due to
ineffective protein expression. To solidify the mitochondrial
dependency of MAVS-induced cell death, we co-expressed MAVS
with the hepatitis C virus (HCV) protein NS3/4A. NS3/4A is a
serine protease which has been shown to target the MAVS TM
domain for cleavage and subsequent inhibition of MAVS antiviral
signaling [4,17]. Consistent with its role in inhibiting MAVS
mediated IFN-I signaling, NS3/4A inhibited MAVS induced
apoptosis (Fig. 4B, bottom right panel). The inhibitory effects of
Figure 1. MAVS induces cell death. (A) MAVS overexpression in HEK293T cells results in cell death. (B) MAVS-induced cell death displays dose
dependency determined by Trypan blue exclusion cell counting. Cells were harvested for Trypan Blue counting 48 h post-transfection. (C) In the XTT
cell viability assay, 1.0610
4 HEK293T were plated in 96-well plate, and increasing doses of MAVS from 0 ng/well to 200 ng/well were transfected and
total amount of plasmids for each well was maintained at 400 ng by mixing pcDNA3 and MAVS plasmids together. XTT assays were performed
48 hours post-transfection. Error bar represents standard deviation of triplicates of biological samples and each graph represents three individual
experiments.
doi:10.1371/journal.pone.0005466.g001
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measurement of cell viability via XTT assay (Fig. 4C). Mitochon-
drial membrane potential collapse marks a point-of-no-return
during apoptosis and occurs earlier than DNA fragmentation
[38,39]. Only wildtype MAVS resulted in compromised mito-
chondrial membrane potential as measured by TMRE staining
while the addition of NS3/4A abrogated this effect (Fig. 4D).
MAVS-induced apoptosis is independent of type-1
interferon production or NF-kB activity
It has been shown that exogenous MAVS expression triggers
IFN-I production [1,5]. Type-1 IFNs mediate their effects by
binding to cell surface receptors, activating downstream interfer-
on-stimulated genes or ISGs, among which more than 15 genes
have pro-apoptotic functions [40]. We sought to determine if
MAVS-induced apoptosis was the result of activation of a
distinctive signaling pathway or as a consequence of IFN
production. First, we induced IFN-I production in HEK293T
cells by ectopic expression of upstream signaling molecules that
activate MAVS-mediated IFN production. As previously reported,
a helicase domain truncation mutant of RIG-I [41], full-length
MAVS [1], or MDA-5 in conjunction with its ligand poly(I:C) [42]
zareall potent IFN-I inducers (Fig. S4). NeitherDRIG-I nor MDA-5
plus poly(I:C) induced any observable cell death or Annexin V-
positive cells (Fig. 5A, bottom panels). Only full-length MAVS
triggered apoptosis as quantified by Annexin V and 7-AAD staining
(Fig. 5A, top right panel). To explore the role of IFN-b in MAVS-
induced apoptosis, HEK293T cells were treated with 200 neutral-
ization IU/ml IFN-b antibody prior to transient expression of
MAVS followed by XTT measurements. We found that blocking
IFN-b from binding to its cell surface receptor had no effect on
MAVS-induced apoptosis (Fig. 5B) even though the antibody
efficiently blocked the function of secreted IFN-b (Fig. S5). In
congruence with these findings, rSeV-GFP infections of the
interferon-a/b receptor (IFNAR) knockout and wildtype MEFs
demonstrated that this receptor is not required for SeV-induced cell
death as visualized by PI staining (Fig. 5C). MAVS is also capable of
inducing the transcription factor NF-kB, which is known to activate
a wide array of genes linked to immune, inflammatory, and cell-fate
processes [43]. To test the involvement of NF-kB in MAVS-induced
apoptosis, we co-expressed MAVS with the non-degradable super-
repressor form of IkBa. This super-repressor is a known potent
inhibitor of NF-kB activation and as expected inhibited MAVS-
induced NF-kB activation (Fig. S6) [44]. However, transient
expression of MAVS in HEK293T cells induced apoptosis even in
the presence of the NF-kB super-repressor (Fig. 5D). There are 14
subtypes of type-1 IFNs, and a plethora of other secreted soluble
factors can be induced by MAVS expression. Therefore, we
performed a transwell assay designed to definitively answer if
MAVS-induced cell death was intrinsic to the host cell or caused by
some unknown secretory factor. HEK293T cells were plated in two
different chambers (top and bottom) separated by an insert filter
membrane, permissive to all secretory cytokines but impermeable to
FuGENE6:DNA complexes. In this experiment, only the lower
Figure 2. MAVS expression leads to apoptosis. (A) MAVS-induced cell death is caspase-dependent. HEK293T cells were treated with a pan-
caspase inhibitor z-VAD-FMK before transfection with a titration doses of MAVS, and cell viability was measured by XTT assay. (B) MAVS triggers PARP
cleavage as well as the activation of caspase-3 and caspase-9. One million HEK293T cells were transfected with 1 mgo r3mg of MAVS-expressing
plasmids and harvested 24 h or 48 h post-transfection. Cell extracts were immunoblotted for PARP, caspase-3 and caspase-9. (C) Densitometry
analysis on the Western blot shown in (B). (D) Apoptotic morphological features of MAVS-induced cell death. Three micrograms of MAVS plasmids
were transfected into 5610
5 HEK-293T cells. Transmission electron microscopy (TEM) analysis was carried out 48 hours post-transfection. Arrows: (I)
intact plasma membrane; (II) marginated and condensed chromatin; (III) large vacuole; (IV) swollen mitochondria. Each graph represents two
individual experiments.
doi:10.1371/journal.pone.0005466.g002
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were not transfected with MAVS, but were exposed to the same
cytokine milieu. As expected, MAVS induced cell death in the lower
chamber (transfected cells); however the cells in the upper chamber
(untransfected cells) remained healthy and unchanged from controls
(Fig. 5E). This indicates that the MAVS-induced death is not caused
by an undefined secretory product(s) which includes the interferon
family members. IRF3 is a critical transcription factor for IFN-I
production but it has been associated with apoptosis, and
furthermore can be activated by MAVS [37,45]. We assessed
whether MAVS-induced apoptotic signaling depends on IRF3. We
made numerous attempts to introduce MAVS into IRF3
2/2
fibroblasts, however these cells were much more difficult to transfect
than wildtype fibroblasts, hence the different efficiencies of
transfection made the interpretation of data difficult. Instead we
used siRNA to reduce IRF3 expression. Briefly, HEK293T cells
were plated in 96-well plate and endogenous IRF3 expression was
reduced by transfecting a pool of four siRNA into the cells. MAVS
was introduced 24 hours after siRNA transfection. Cell viability was
measured by XTT assay 48 hours after cells were transfected with
an expression plasmid containing MAVS or a control empty vector.
The reduction of IRF3 did not prevent MAVS-induced loss of cell
viability (Figure 6A). The same siRNA was introduced into 5610
5
cells plated in a 6-well plate, and an immunoblot was used to verify
the efficiency of siRNA 48 h post-transfection (Figure 6B). As an
alternate approach to measure cell death, the experiment was
repeated in 6 well plates and cells were harvested 48 hours after
plasmids transfection. Half of the cells from each well were stained
for Annexin V and analyzed by flow cytometry, and the other half of
the cells were lysed in RIPA buffer for Western blotting analyses of
IRF3. As expected we were able to greatly reduce the endogenous
IRF3 expression, yet MAVS-induced apoptosis was not abrogated
(Fig. 6C, 6D).
The SARS-CoV non-structural protein 15 inhibits MAVS-
induced apoptosis
While host response that elicits apoptosis may function as an
antiviral strategy, viruses have also evolved diverse mechanisms to
evade these host antiviral responses. Therefore we performed a
functional screen of 12 SARS-CoV-encoded proteins to identify
any potential modulators of MAVS-induced apoptosis. Each of
Figure 3. MAVS mediates SeV-induced apoptosis in primary fibroblasts. (A) MAVS is critical for SeV-induced apoptosis. MAVS wild type and
knockout MEFs were infected with recombinant Sendai virus expressing GFP at a MOI of 0.5. Forty-eight hours post-infection, GFP-positive cells were
gated (top graph) and then subjected to Annexin V binding analysis (bottom graph) by flow cytometry. (B) MAVS wild type and knockout MEFs were
infected with rSeV-GFP at the MOI of 0.5. Forty-eight hours post-infection, cells were stained with Hoechst blue and Propidium Iodide (PI). (C)
Morphological features of MAVS wild type and knock out MEFs infected by SeV. TEM pictures were taken 48 h post-infection. While SeV infected
wildtype cells displayed morphology typical of apoptotic cells, SeV infected MAVS
2/2 cells did not exhibit such morphology. Each graph represents
two separate experiments.
doi:10.1371/journal.pone.0005466.g003
MAVS Mediates Apoptosis
PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5466these SARS-CoV genes were cloned into an expression vector and
co-expressed with MAVS plasmid followed by XTT cell viability
measurements. Protein expression was verified by an immunoblot
(Fig. S7). Of the 12 tested proteins, only one SARS-CoV protein,
NSP15, significantlyalteredMAVS-inducedapoptosisofHEK293T
cells (Fig. 7A). Further examination showed that NSP15 significantly
inhibited MAVS-induced apoptosis in a dose-dependent manner
(Fig. 7B). The anti-apoptotic function of NSP15 displayed specificity
since it did not inhibit staurosporine-induced apoptosis (Fig. 7C). We
sought to investigate if the anti-apoptotic function of NSP15 was
specific for SARS-CoV or shared by other coronaviruses. When the
NSP15 protein encoded by the SARS-CoV, HKU1 or NL63
genome was coexpressed with MAVS, only SARS-CoV NSP15
inhibitedMAVS-mediatedapoptosisasmeasuredbyAnnexinVand
7-AAD staining, while the others showed little effect on cell viability
(Fig. 7D).
Discussion
Host cellular response to virus infection involves the concom-
itant activation of parallel signaling pathways leading to the
transcription of a plethora of cytokine genes, prominent among
these are the genes encoding type-1 interferons (IFN-I). It is the
autocrine and paracrine action of these and other cytokines which
encompasses the comprehensive host immune response designed
to defend against viral infection. This is accompanied by a
reciprocal activation of programmed cell death in infected host
cells, which is also known to reduce viral load. Apoptosis has been
suggested to play a protective role at the organismal level in
preventing the virus from completing its replication and producing
infectious progeny viruses [19]. Consequently, the exact mecha-
nisms underlying both virus-induced apoptotic signaling in
addition to viral strategies to subvert these responses is currently
a topic of intensive research. While pathways that govern IFN-I
have been extensively investigated, the molecular mediators that
activate host cell apoptosis during viral infection are less known. In
this study we have identified a role for MAVS in the initiation of
virus-induced apoptosis (Fig. 8). Furthermore, we have identified
hepatitis C virus NS3/4A and SARS-CoV NSP15 proteins as
inhibitors of MAVS-mediated apoptosis.
It is known that MAVS is a potent inducer of IFN-I responses
and that IFN-I can activate host apoptotic responses, therefore it
was important to determine whether the cell death responses
observed in the current study were a consequence of IFN-I
secretion. In fact, IFN-I consist of several species including IFN-a,
IFN-b, IFN-v and IFN-k and these cytokines bind to surface
Figure 4. Distinct MAVS domains are required for apoptosis. (A) The domain structure of MAVS. MAVS contains a N-terminal CARD-like
domain, a C-terminal transmembrane domain (TM) and a central proline-rich region. The cartoon shows the structure of the three truncation mutants
we used in the study. (B) The TM and CARD-like domains are not dispensable for the pro-apoptotic function of MAVS. 1 mg of wildtype MAVS and its
three mutants depicted in (A) were introduced in HEK293T cells; and apoptosis was assessed by flow cytometry 48 h post-transfection using 7-AAD
and Annexin V as markers of dead and apoptotic cells respectively. (C) The mitochondrial localization of MAVS is critical for its pro-apoptotic function.
Cell viability was determined by XTT assay. (D) MAVS induces mitochondrial membrane potential collapse in HEK293T cells as quantified by TMRE
staining. Each graph represents two separate experiments.
doi:10.1371/journal.pone.0005466.g004
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transduction pathway resulting in the transcriptional activation
of virtually hundreds of IFN-stumulated genes (ISGs), whose
protein products play pivotal roles in a variety of biological
events, including but not limited to immunomodulation, cell
differentiation, anti-angiogenesis and programmed cell death.
For example, type-1 IFN induction of apoptotic responses can be
mediated by a multitude of ISGs, illustrated by the finding that
more than 15 ISGs have pro-apoptotic functions [40]. In
addition, the involvement of proteins on IFN axis in virus-
induced host cell apoptosis has been implicated in another
previous report, in which MAVS has been shown to be critical
for reovirus-triggered caspase-3/7 activation in HEK293T cells
[46], however, the study did not evaluate whether MAVS
mediates virus-induced apoptosis and what roles type 1 IFNs
play in MAVS-mediated apoptosis. Using a multi-pronged
approach we demonstrate that MAVS-mediated apoptosis is
not a consequence of IFN-I induction by MAVS. We show that
(a) the over-expression of the truncation mutant of RIG-I that
induce IFN-I does not lead to apoptosis; (b) anti-IFN-b antibody
does not ablate MAVS-induced apoptosis; (c) the targeted
deletion of IFN receptor does not alter MAVS-induced
apoptosis; (d) the co-culture of MAVS-transfected cells with
nontransfected cells separated by an insert filter membrane does
not induce apoptosis in the latter, indicating that a soluble
secretory factor is not likely responsible for the apoptosis-
inducing activity.
In the IFN-I induction pathway mediated by endogenous RIG-I
like helicases, IRF3 lies downstream of MAVS, and exogenous
expression of MAVS can lead to the phosphorylation and nuclear
translocation of IRF3 [1]. In addition, others have shown that the
expression of constitutively active form of IRF3 mutant is toxic to
cells and the transfection of wild type IRF3 expression can
augment SeV-induced apoptosis [37,45]. Hence it was important
to evaluate if MAVS-induced apoptosis depends on the presence
of IRF3. Our data shows that depletion of endogenous IRF3 by
means of RNAi did not reverse MAVS-induced cell viability loss.
Together with our findings that MAVS-induced apoptosis is IFN-
Figure 5. MAVS-induced apoptosis is independent of type I IFNs production. (A) Three molecules (DRIG-I, MDA5 and MAVS) that activate
the production of type I IFNs were introduced into HEK293T cells; only MAVS is able to induce apoptosis. (B) Anti-IFN-b antibody was added to the
medium at the final concentration of 200 neutralization units/ml to prevent secreted IFN-b binding to IFNAR, this neutralization process did not
inhibit MAVS-induced apoptosis. (C) SeV-induced apoptosis is IFN-I-independent. MEFs from both C57BL/6 wild type and IFNAR
2/2 mice were
infected with rSeV-GFP. Cells were stained with Hoechst and PI 48 h post-infection. (D) The non-degradable form of IkB was co-expressed with
different doses of MAVS, yet cell viability loss was not restored. (E) HEK293T cells were plated at both the lower chamber and upper chamber of the
transwell plate separated by an insert filter membrane with 0.4 mm pore size. 1 mg of MAVS-containing plasmid was transfected into the cells in the
lower chamber and all cells were harvested 48 h post-transfection for flow cytometry analysis.
doi:10.1371/journal.pone.0005466.g005
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signaling pathway is different from the classical MAVS-mediated
IFN-I response. Furthermore, it is possible that the reported pro-
apoptotic effects of the constitutively active form of IRF3 might be
independent of its IFN-I-inducing function. In fact our data
suggests other IFN-I signaling molecules such as the constitutively
active form of RIG-I and MDA5 do not lead to apoptosis despite
of their roles in inducing IFN-I.
The dual functions of MAVS in virus-induced IFN-I and
apoptosis highlight this molecule as a putative target for viral
evasion strategies designed to escape host immunity. For example,
it is already known that Hepatitis C Virus (HCV) produces a serine
protease, NS3/4A, which disrupts IFN-I production through the
targeted cleavage of the MAVS transmembrane region and the
subsequent dislodging of MAVS from the mitochondria [4,16]. In
fact, we found that loss of MAVS mitochondrial localization
through mutation of the transmembrane domain, also completely
abolished its pro-apoptotic effects. Consistent with these results,
when HCV NS3/4A protein was co-expressed with MAVS, this
viral protein completely inhibited MAVS-induced cell death. This
result would suggest that the host immune evasion strategies of the
HCV NS3/4A protein may be extended to inhibition of MAVS-
mediated apoptosis. Similarly hepatitis A virus (HAV), a
picornavirus, employs a cysteine protease 3ABC to abrogate
IFN-I production by targeting MAVS [17]. Therefore, it is likely
that other uncharacterized viral mechanisms target MAVS for
modulation of host cell death responses.
One novel strategy described in this study is employed by the
SARS-CoV. Similar to SARS-CoV abilities to inhibit IFN-I
responses, we have found that this virus is also capable of
interfering with host cell death responses by targeting MAVS. We
showed that among the 12 SARS-CoV proteins tested, NSP15
Figure 6. MAVS-induced apoptosis does not depend on IRF3. (A) 1.0610
4 HEK293T cells were plated in 96-well plates, a pool of four siRNA
targeting IRF3 or control siRNA were added to each well, 24 hours later 200 ng MAVS or empty vector plasmids were transfected into the cell. XTT assay
was performed 48 hours thereafter. Error bars shown in the plot represents three biological replicates. (B) The same IRF3-targeting and non-targeting
siRNA transfection reagents used in (A) were applied to 5.0610
5 cells, and all cells were lysed in RIPA buffer 48 hours post-transfection and subjected to
Western blotting to confirm knockdown. (C) 5.0610
5 HEK293T cells were plated in 6-well plates and treated with IRF3 or control siRNAs, 24 hours later
3 mg of MAVS expression plasmid or empty vector plasmids were introduced into the cells. Half of the cells from each well were harvested 48 hours
thereafter and stained with Annexin V. The plot represents two separate experiments and the percentages of Annexin V positive cells were averaged for
quantification.(D) The other half ofthe cells describedin(C) were lysedin RIPAbuffer and subjectedtowestern blotanalysestoconfirm IRF3knockdown.
doi:10.1371/journal.pone.0005466.g006
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underlying mechanism is currently unclear since the function of
NSP15 is not yet fully defined. However, an earlier report
indicates that this protein is indeed important for SARS
pathogenesis in that it is essential for viral replication [47].
However, until we understand the exact temporal expression
patterns of each of the SARS-CoV proteins during the course of
an infection, the relative contributions of each to the evasion of
host immunity and apoptosis will not be fully understood. Further
studies are needed to determine the exact mechanism of action for
NSP15 on inhibiting MAVS-induced cell death. Since SARS-CoV
replication is limited to the first two weeks after symptom onset
and NSP15 is critical for its replication [33,47], this would support
the theory that NSP15 may function as an inhibitor of host cell
death during this time, which would possibly benefit viral
replication. Further studies are ongoing to determine how
NSP15 and other SARS-CoV proteins contribute to overall viral
evasion strategies.
The finding that MAVS mediates virus-induced apoptosis posits
a new mechanism by which mitochondria serves as a bona fide
intracellular sentinel for antiviral and apoptotic responses. It is well
established that the permeabilization of the mitochondria outer
membrane by the pro-apoptotic Bcl-2 family member BAK results
in the activation of caspase-9 in a classical Apaf-1-dependent or an
alternate Apaf-1-independent pattern [48]. Furthermore, it is
known that proteins localized on the mitochondria are targeted by
viruses to modulate host responses. For example, the cytomega-
lovirus RNA can interact with the mitochondrial enzyme complex
I (reduced nicotinamide adenine dinucleotide–ubiquinone oxido-
reductase) to modulate the classical mitochondria-mediated
apoptosis [49]. Recent discoveries also underscore the mitochon-
dria as a platform orchestrating host antiviral type-1 IFNs through
the mitochondrial MAVS protein. This study describes, for the
first time, a duality of function for the MAVS protein in regulating
both IFN-I and apoptotic antiviral responses from within the
mitochondria and suggests that MAVS is a pivotal molecule in the
bifurcation of host responses following viral challenge. Further-
more, the identification of HCV NS3/4A and SARS-CoV NSP15
as inhibitors of MAVS-mediated apoptotic responses reveals both
novel host defense mechanisms as well as viral immune-evasion
mechanisms that might serve as useful templates for the
development of anti-viral drug strategies.
Materials and Methods
Cells and Plasmids
HEK293T cells, MAVS
+/+, MAVS
2/2, IFNAR
2/2 mouse
embryonic fibroblasts were maintained in DMEM media
supplemented with 10% FBS, 1% penicillin and 100 mg/ml
streptomycin. Cells were passed every three days and grown at
37uCi n5 %C O 2.
The mammalian expression plasmids of NS3/4A, wild type
MAVS and truncation mutants were kindly provided by Dr.
Zhijian Chen at the University of Texas southwestern medical
center. HA-tagged SARS-CoV proteins expression plasmids,
HKU1 NSP15 and NL63 NSP15 expression plasmids were
provided by Drs. Ralph Baric and Matthew Frieman at the
University of North Carolina.
Figure 7. The SARS-CoV NSP15 protein abrogates MAVS-induced apoptosis. (A) Twelve of the SARS-CoV proteins were co-expressed with
MAVS and NSP15 is the only one that exhibited a potent inhibitory effect on MAVS-induced apoptosis as assessed by XTT cell viability assay. (B) The
inhibitory effect of NSP15 displays dose-dependency. Cell death was measured by an adenylate kinase activity assay. (C) The anti-apoptotic function
of NSP15 does not extend to staurosporine-induced cell death. NSP15-expressing plasmid or empty vector were transfected in HEK293T cells seeded
on 96-well plate, cells were treated with 500 nM staurosporin or PBS 24 h post-transfection, cell death fold change was evaluated by the adenylate
kinase activity assay. (D) The inhibitory effects of NSP15 is unique to SARS-CoV. MAVS was co-expressed with NSP15 encoded by SARS-CoV, HKU1 and
NL63. Flow cytometry analysis of 7-AAD/Annexin V stained cells was performed 48 h post-transfection. The results represent two separate
experiments.
doi:10.1371/journal.pone.0005466.g007
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HEK293T cells were seeded in 96-well or 6-well plates, and the
total DNA transfected into these cells was 400 ng/well and 1 mg/
well respectively. Standard transfection protocol was performed
using FuGENE6 (Roche Applied Science) according to the
commercial protocol. Cells were incubated for the indicated times
prior to assay.
rSeV-GFP is a recombinant Sendai virus expressing GFP and
was originally made by Dr. Daniel Kolakofsky [50]. For viral
infections, 1.6610
4 MEFs were plated into 12-well plate one day
prior to Sendai virus (SeV) infection. Viral infections were
performed when cells reached 60% confluence. MEFs were
incubated with SeV for 1 h in serum-free DMEM supplemented
with 0.5% trypLE Select at the MOI of 0.5. Serum-free DMEM
supplemented with 0.5% trypLE Select was used for mock
infection. Virus inoculum was removed and cells were replenished
with complete media supplemented with 0.5% trypLE Select
following incubation with virus.
Cell Viability Assays
XTT salt (Sigma, St. Louis, MO) (1 mg/ml) was dissolved in
serum-free media and phenazine methosulfate (PMS) (5 mM)
(Sigma, St. Louis, MO) solution was prepared fresh. For activated
XTT solution, both solutions were mixed at a ratio of 5 ml of PMS
per 1 ml XTT. 50 ml of activated XTT solution was added to each
96 well (1610
4 cells/well), incubated at 37uC for 4 hours and
absorbance was read at a wavelength of 450 nm. An adenylate
kinase non-destructive cytotoxicity assay was performed utilizing
the ToxiLight bioassay kit (Lonza) following the manufacturers
standard protocol for adherent cells in a 96 well plate. For Trypan
blue exclusion test of cell viability, 10 ml of cell suspension was
mixed with 10 ml of 0.4% Trypan blue solution (Sigma, St.Louis,
MO), and both unstained (viable) and stained (dead) cells were
counted on the hemacytometer. The percent of dead cells was
calculated by dividing the number of stained cells by the total
number of cells.
Flow Cytometry
Cells were harvested and washed in cold FACS buffer (5% FBS
in 16 PBS) twice and in 16 Annexin V binding buffer (BD
Bioscience, San Diego, CA) once. Cells were transferred into 96-
well plate and resuspended in 45 ml Annexin V binding buffer.
Cells were stained according to standard cell staining protocol [51]
using Annexin V conjugated to FITC or APC (BD Biosciences,
San Diego, CA). Cells were washed in FACS buffer and stained
with 7-AAD (Invitrogen, Carlsbad, CA) for 10 min at room
temperature. Cells were washed twice and resuspended in FACS
buffer containing 1 mg/ml Actinomycin D. After 5 min incuba-
tion, all samples were fixed in 500 ml 1% EM grade formaldehyde
(Polysciences, Warrington, PA) for immediate flow cytometry
analyses. For the rSeV-GFP infected samples, GFP positive cells
were gated; Annexin V and 7-AAD positive populations were
assessed thereafter.
Mitochondrial membrane potential Dy was assessed by flow
cytometry analysis on a Dy- sensitive fluorophore tetramethylrho-
Figure 8. A proposed model for the dual functions of MAVS. MAVS is engaged in two distinct host protective responses to viral infections.
Upon activation by RNA viruses, MAVS initiates type 1 IFN signaling by activating the nuclear translocation of NF-kB and IRF3. In addition, host cells
could mount apoptotic responses to viruses such as SeV via MAVS. Notably MAVS is targeted by viruses not only for abrogating IFN-I production but
also inhibiting host apoptosis. For example, HCV NS3/4A and SARS-CoV NSP15 proteins abrogate MAVS-mediated apoptosis.
doi:10.1371/journal.pone.0005466.g008
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treatment, HEK293T cells were incubated with TMRE at the
concentration of 10 nM per 1610
6 cells for 40 min at 37uC.
Immediate flow cytometry analysis was performed after staining.
All flow cytometry data were collected on either a FACSCalibur
(BD Biosciences, San Jose, CA) or CyAn flow cytometer (Dako
North America, Carpinteria, CA) and then analyzed by FlowJo
software (Tree Star, Ashland, OR).
Imaging
Transmission electron microscopy examination was performed
as described [52]. MEFs or HEK293T cells were harvested and
fixed in glutaraldehyde and all samples were post-fixed in 1%
OsO4 for transmission electron microscopy examination. Cells
were embedded in London Resin White and sections were
analyzed using a LEO EM-910 transmission electron microscope
(LEO Electron Microscopy Inc., Thornwood, NY). Hoechst and
Propidium Iodide (PI) dual staining was used to evaluate SeV-
induced cell death. Samples were photographed using a Leica
DMIRB inverted fluorescence microscope (Leica Microsystems
Inc., Bannockburn, IL) with a digital camera (MicroPublisher, Q-
Imaging, Burnaby, BC, Canada).
Immunoblotting
Cells were lysed in RIPA lysis buffer (1% Triton X-100, 0.25%
DOC, 0.05% SDS, 50 mM Tris pH8.0, 150 mM NaCl and
50 mM NaF) containing proteinase inhibitor cocktails (Roche) for
30 min at 4uC. Whole cell lysates were suspended in Laemmli’s
sample buffer and loaded onto NuPAGE Bis-Tris 4–12% gradient
pre-cast gels (Invitrogen, Carlsbad, CA) for SDS-PAGE and
subsequent immunoblotting for PARP, caspase-3 and caspase-9
(Abcam, Cambridge, MA), IRF3 (Santa Cruz Biotechnology,
Santa Cruz, CA), rodent specific MAVS (Cell Signaling, Danvers,
MA). Densitometry was performed using ImageJ analysis software.
Caspase and Interferon inhibition treatments
HEK293T cells were incubated with 50 mM Z-VAD-FMK to
inhibit caspase activity. HEK293T cells were treated with human
IFN-b neutralizing antibody (GeneTex, San Antonio, TX) at the
concentration of 200 neutralization units/ml.
Small interference RNA depletion of endogenous IRF3
HEK293T cells were transfected with a pool of four targeting
siRNA according to the manufacturer’s protocol (Dharmacon,
Chicago, IL). The sequences are: (1) sense 59-CGAGGCCACUG-
GUGCAUAUUU, antisense 59-AUAUGCACCAGUGGCCUC-
GUU; (2) sense 59-CCAGACACCUCUCCGGACAUU, anti-
sense 59-UGUCCGGAGAGGUGUCUGGUU; (3) sense 59-
GGAGUGAUGAGCUACGUGAUU, antisense 59-UCAC-
GUAGCUCAUCACUCCUU; (4) sense 59-AGACAUUCUG-
GAUGAGUUAUU, antisense 59-UAACUCAUCCAGAAUGU-
CUUU. A pool of 4 non-targeting siRNAs were used as control.
Empty vector or MAVS expression plasmids were introduced into
the cells 24 hours after the transfection of siRNA.
Transwell Assay
HEK293T cells were seeded on the bottom of both chambers in
a HTS 24-well transwell plate with 0.4 mm pore polycarbonate
membrane (Corning Incorporated Life Sciences, Lowell, MA).
MAVS expression plasmid DNA was transfected into the cells on
the bottom of lower chamber and flow cytometry analysis on
apoptosis was performed 48 h post-transfection on cells grown in
each chamber.
Supporting Information
Figure S1 The kinetics of MAVS expression and MAVS-induced
apoptosis. (A) 56105 HEK293T cells were plated in 6 well plate,
3 mg MAVS plasmids were transfected at 3 h, 12 h, 24 h and 48 h
prior to cell harvesting. Half of the cells were lysed in RIPA buffer
and blotted with anti-FLAG to determine the protein expression
kinetics. (B) The other half of the cells from each well were stained
with Annexin V and analyzed by flow cytometry.
Found at: doi:10.1371/journal.pone.0005466.s001 (11.68 MB
TIF)
Figure S2 Confirmation of MAVS knockout by Western Blot.
One million MAVS+/+ and MAVS2/2 MEFs were lysed in
RIPA buffer containing proteinase inhibitor cocktail. Cell extracts
were subjected to SDS-PAGE and Western blotting for rodent-
specific MAVS.
Found at: doi:10.1371/journal.pone.0005466.s002 (2.15 MB TIF)
Figure S3 Expression test of MAVS truncation mutants. 3 mg
FLAG-MAVS wild type, FLAG-MAVSDCARD, FLAG-
MAVSDpro and HA-MAVSDTM plasmids were transfected to
56105 HEK-293T cells seeded in 6 well plate. Cell were harvested
24 h post-transfection and blotted with anti-FLAG or anti-HA
antibody to confirm protein expression efficiency.
Found at: doi:10.1371/journal.pone.0005466.s003 (4.71 MB TIF)
Figure S4 MAVS, DRIG-I and MDA5 plus Poly (I:C) induce
increased transcription of IFNB1 and IFNA4. 56105 HEK293T
cells were seeded in 6-well plates and grown overnight. 1 mgo f
MAVS and DRIG-I plasmids were transfected into the cells the next
day, similarly 1 mg MDA5 and 100 ng poly (I:C) wereco-transfected
into the cells as well. RNA samples were extracted from each group
of cells 24 h post-transfection and subjected to real time RT-PCR
analyses on the transcripts of IFNB1 and IFNA4.
Found at: doi:10.1371/journal.pone.0005466.s004 (5.59 MB TIF)
Figure S5 IFN-b neutralizing antibody is able to block the
function of secreted IFN-b. A549 cells were seeded in 96-well plate
at the density of 26104 per well, 1 ml of media or anti-IFN-b
antibody was added to reach the final concentration of 200
neutralization IU/ml the next day. One hour after incubation with
the antibody, recombinant IFN-b was added to culture at a series
of doses from 31.25 to 500 IU/ml. Cells were infected with
Encephalomyocarditis virus (EMCV) at 46106 pfu/ml 16 h after
IFN treatment. The plates were blind scored 24 h post-infection
using ‘‘1’’ as maximal protection (most cells are protected by IFN),
‘‘0.5’’ as about 50% of the cells were not protected by IFN, and
‘‘0’’ as no IFN protection (most cells are dead).
Found at: doi:10.1371/journal.pone.0005466.s005 (6.29 MB TIF)
Figure S6 NF-kB super-repressor inhibits the activity of NF-kB.
HEK293T cells were seeded in 96-well plate at the density of
16104 per well and grown overnight. 25 ng of NF-kB luciferase
reporter construct together with 100 ng MAVS plasmid or NF-kB
super-repressor were transfected into the cells. The plate was read
in a luminometer 24 h post-transfection.
Found at: doi:10.1371/journal.pone.0005466.s006 (5.37 MB TIF)
Figure S7 SARS-CoV proteins were expressed in HEK293T
cells. Twelve SARS-CoV protein-encoding sequences were cloned
into expression vectors with an HA tag. HEK293T cells were
seeded in 6-well plate and transfected with 1 mg plasmid of each
protein when cells reached 60% confluence, all cells were
harvested and lysed 24 h post-transfection for Western blotting
analysis with anti-HA antibody.
Found at: doi:10.1371/journal.pone.0005466.s007 (7.49 MB TIF)
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